VIVUS Executes on its Strategic Vision with the Closing of its Acquisition of PANCREAZE® and Previously Announced Financing Transaction

CAMPBELL, Calif., June 11, 2018 (GLOBE NEWSWIRE) — VIVUS, Inc. (Nasdaq:VVUS) (the “Company”), a biopharmaceutical company, today announced that it…

You must be a paid subscriber to view this content. To become a new paid subscriber, please go to the REGISTER TAB and choose one of the subscription plans.

Leave a Reply

error: Content is protected !!